C12N 2750/00034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2750/00034 (Use of virus or viral component as vaccine) appears on 9 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 16
- Assignees
- 8
- Inventors
- 28
- Latest grant
- 4 Sep 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 4 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 2 | 2 |
| 2017 | 2 | 0 |
| 2018 | 3 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Infectious genomic DNA clone and serological profile of torque teno sus virus 1 and 24 Sep 2018US 10,067,130 B2Virginia Tech Intellectual Properties, Inc.
- Laser-based vaccine adjuvants21 Aug 2018US 10,052,376 B2Alternative Innovative Technologies LLC
- Porcine torque teno virus vaccines and diagnosis20 Feb 2018US 9,897,605 B2Virginia Tech Intellectual Properties, Inc.
- Vaccine formulations comprising saponin-containing adjuvants15 Aug 2017US 9,730,987 B2Merial Limited
- Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity18 Apr 2017US 9,624,511 B2Deutsches Krebsforschungszentrum
- Chicken anemia virus (cav)-based vectors4 Jan 2024US 2024/0000914 A1Flagship Pioneering Innovations V, Inc.
- Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 215 Sep 2016US 2016/0266116 A1Virginia Tech Intellectual Properties, Inc.
- Porcine torque teno virus vaccines and diagnosis28 Jul 2016US 2016/0216263 A1Virginia Tech Intellectual Properties, Inc.
- Specific TT Virus Sequences and Chimeric TT Virus Host Cell DNA Molecules for use in Diagnosis, Prevention and Treatment of Cancer and Autoimmunity3 Sep 2015US 2015/0247165 A1Deutsches Krebsforschungszentrum
- Vaccine Formulations Comprising Saponin-containing Adjuvants16 Jul 2015US 2015/0196487 A1Merial Limited
Most cited
By later US patents
- Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity3US 9,624,511 B2Deutsches Krebsforschungszentrum · 2017
- Vaccine formulations comprising saponin-containing adjuvants3US 9,730,987 B2Merial Limited · 2017
- Infectious genomic DNA clone and serological profile of torque teno sus virus 1 and 21US 10,067,130 B2Virginia Tech Intellectual Properties, Inc. · 2018